Tecogen (OTC:TGEN) reported Q2 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $6.4 million versus the consensus estimate of $7.22 million.
Tecogen (OTC:TGEN) reported Q2 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $6.4 million versus the consensus estimate of $7.22 million.